A detailed history of Bank Of America Corp transactions in Codexis, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 54,056 shares of CDXS stock, worth $220,548. This represents 0.0% of its overall portfolio holdings.

Number of Shares
54,056
Previous 69,744 22.49%
Holding current value
$220,548
Previous $243,000 31.28%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.65 - $3.92 $41,573 - $61,496
-15,688 Reduced 22.49%
54,056 $167,000
Q1 2024

May 15, 2024

SELL
$2.59 - $4.65 $240,256 - $431,347
-92,763 Reduced 57.08%
69,744 $243,000
Q4 2023

Feb 14, 2024

SELL
$1.54 - $3.37 $133,941 - $293,105
-86,975 Reduced 34.86%
162,507 $495,000
Q2 2023

Aug 14, 2023

SELL
$2.21 - $4.43 $294,296 - $589,925
-133,166 Reduced 34.8%
249,482 $698,000
Q1 2023

May 12, 2023

BUY
$3.81 - $6.76 $107,179 - $190,165
28,131 Added 7.94%
382,648 $1.58 Million
Q4 2022

Feb 10, 2023

BUY
$4.26 - $6.84 $270,808 - $434,818
63,570 Added 21.85%
354,517 $1.65 Million
Q3 2022

Nov 14, 2022

BUY
$6.06 - $12.86 $717,782 - $1.52 Million
118,446 Added 68.66%
290,947 $1.76 Million
Q2 2022

Aug 12, 2022

BUY
$8.35 - $21.89 $1.22 Million - $3.2 Million
146,057 Added 552.33%
172,501 $1.8 Million
Q1 2022

May 16, 2022

SELL
$16.97 - $31.93 $195,188 - $367,258
-11,502 Reduced 30.31%
26,444 $545,000
Q4 2021

Feb 08, 2022

SELL
$25.61 - $41.78 $511,098 - $833,803
-19,957 Reduced 34.47%
37,946 $1.19 Million
Q3 2021

Nov 15, 2021

SELL
$19.65 - $27.99 $110,295 - $157,107
-5,613 Reduced 8.84%
57,903 $1.35 Million
Q2 2021

Sep 13, 2021

BUY
$17.48 - $25.46 $1.11 Million - $1.62 Million
63,516 New
63,516 $1.44 Million

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $267M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.